Cargando…

In vitro susceptibility of Escherichia coli strains isolated from urine samples obtained in mainland China to fosfomycin trometamol and other antibiotics: a 9-year surveillance study (2004–2012)

BACKGROUND: As a result of extensive use of fluroquinlones and cephalosporins, urinary tract pathogens producing extended-spectrum beta-lactamase (ESBL) pose a considerable clinical challenge in the treatment of UTIs. In the present study we retrospectively assessed the susceptibility of E. coli str...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lai, Bei, Zheng, Bo, Li, Yun, Zhu, Sainan, Tong, Zhaohui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3922505/ https://www.ncbi.nlm.nih.gov/pubmed/24502648 http://dx.doi.org/10.1186/1471-2334-14-66

Ejemplares similares

Antimicrobial Susceptibility and Molecular Mechanisms of Fosfomycin Resistance in Clinical Escherichia coli Isolates in Mainland China
por: Li, Ya, et al.
Publicado: (2015)

Fosfomycin Pharmacokinetic Profile in Plasma and Urine and Quantitative Estimation in Prostate and Seminal Vesicles after One and Two Consecutive Doses of Oral Fosfomycin Trometamol in Healthy Male Volunteers
por: Di Stefano, Andrea F. D., et al.
Publicado: (2022)

Efficacy and Safety of Oral Fosfomycin-Trometamol in Male Urinary Tract Infections with Multidrug-Resistant Enterobacterales
por: Bouiller, Kévin, et al.
Publicado: (2022)

Mechanism of Reduced Susceptibility to Fosfomycin in Escherichia coli Clinical Isolates
por: Ohkoshi, Yasuo, et al.
Publicado: (2017)

Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in Escherichia coli Isolated in Clinical Urine Samples
por: Sorlozano-Puerto, Antonio, et al.
Publicado: (2020)

Antimicrobial Susceptibilities of Urinary Extended-spectrum β-lactamase Escherichia coli to Fosfomycin
por: Saeed, Nermin Kamal, et al.
Publicado: (2021)

611. Fosfomycin Resistance of Multidrug-Resistant Escherichia coli and Mechanisms of Fosfomycin Resistance
por: Seok, Hyeri, et al.
Publicado: (2019)

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA
por: Alrowais, Hind, et al.
Publicado: (2015)

Trometamol: No improvement: case report
Publicado: (2022)

Fosfomycin trometamol vs ciprofloxacin for antibiotic prophylaxis before transrectal ultrasonography-guided prostate biopsy: A meta-analysis of clinical studies
por: Freitas, Daniel Melecchi de Oliveira, et al.
Publicado: (2019)

Effect of Glycerol on Fosfomycin Activity against Escherichia coli
por: Ortiz-Padilla, Miriam, et al.
Publicado: (2022)

Inactivation of ackA and pta Genes Reduces GlpT Expression and Susceptibility to Fosfomycin in Escherichia coli
por: Hirakawa, Hidetada, et al.
Publicado: (2023)

Susceptibility of Escherichia coli from Community-Acquired Urinary Tract Infection to Fosfomycin, Nitrofurantoin, and Temocillin in Korea
por: Seo, Mi-Ran, et al.
Publicado: (2014)

Novel Chromosomal Mutations Responsible for Fosfomycin Resistance in Escherichia coli
por: Cattoir, Vincent, et al.
Publicado: (2020)

Resensitization of Fosfomycin-Resistant Escherichia coli Using the CRISPR System
por: Walflor, Haniel Siqueira Mortagua, et al.
Publicado: (2022)

Determination of Extended-Spectrum β-Lactamases and AmpC Production in Uropathogenic Isolates of Escherichia coli and Susceptibility to Fosfomycin
por: Gupta, Varsha, et al.
Publicado: (2013)

Fosfomycin Resistance in Escherichia coli Isolates from South Korea and in vitro Activity of Fosfomycin Alone and in Combination with Other Antibiotics
por: Seok, Hyeri, et al.
Publicado: (2020)

Anaphylaxis after intravenous infusion of dexketoprofen trometamol
por: Guler, Sertac, et al.
Publicado: (2016)

Markov Networks of Collateral Resistance: National Antimicrobial Resistance Monitoring System Surveillance Results from Escherichia coli Isolates, 2004-2012
por: Love, William J., et al.
Publicado: (2016)

Evaluation of the analgesic efficacies of Dexketoprofen Trometamol and Dexketoprofen Trometamol + Thiocolchicoside combinations in the impacted third molar surgery: Randomised clinical trial
por: Cigerim, Levent, et al.
Publicado: (2019)

Synergistic Effects from Combination of Cryptotanshinone and Fosfomycin Against Fosfomycin-Susceptible and Fosfomycin-Resistant Staphylococcus aureus
por: Ruan, Zijing, et al.
Publicado: (2020)

Nitrofurantoin and Fosfomycin for Extended Spectrum Beta-lactamases Producing Escherichia coli and Klebsiella pneumoniae
por: Tulara, Neeraj Kumar
Publicado: (2018)

Emergence of Plasmid-Mediated Fosfomycin-Resistance Genes among Escherichia coli Isolates, France
por: Benzerara, Yahia, et al.
Publicado: (2017)

Synergistic Activity of Fosfomycin, Ciprofloxacin, and Gentamicin Against Escherichia coli and Pseudomonas aeruginosa Biofilms
por: Wang, Lei, et al.
Publicado: (2019)

Pharmacokinetics of fosfomycin in patients with prophylactic treatment for recurrent Escherichia coli urinary tract infection
por: Kuiper, Sander G, et al.
Publicado: (2020)

Plasma and Urine Pharmacokinetics of Oral Fosfomycin Tromethamine in Dogs
por: Jariyapamornkoon, Nattha, et al.
Publicado: (2023)

652. Comparison of fosfomycin (FOF) activity and prevalence of subpopulations between Escherichia coli (EC) and Klebsiella pneumoniae (KP) during susceptibility testing
por: Anderson, Jadyn C, et al.
Publicado: (2020)

Investigation of sumatriptan and ketorolac trometamol in the human experimental model of headache
por: Ghanizada, Hashmat, et al.
Publicado: (2020)

Postoperative Prevention of Urinary Tract Infections in Patients after Urogynecological Surgeries—Nonantibiotic Herbal (Canephron) versus Antibiotic Prophylaxis (Fosfomycin Trometamol): A Parallel-Group, Randomized, Noninferiority Experimental Trial
por: Wawrysiuk, Sara, et al.
Publicado: (2022)

Oral Fosfomycin for the Treatment of Acute and Chronic Bacterial Prostatitis Caused by Multidrug-Resistant Escherichia coli
por: Zhanel, George G., et al.
Publicado: (2018)

In vivo acquisition of fosfomycin resistance in Escherichia coli by fosA transmission from commensal flora
por: ten Doesschate, Thijs, et al.
Publicado: (2019)

Efficacy of Fosfomycin against Planktonic and Biofilm-Associated MDR Uropathogenic Escherichia coli Clinical Isolates
por: Dzib-Baak, Haziel Eleazar, et al.
Publicado: (2022)

Evaluation of in vitro susceptibility of fosfomycin among Enterobacteriaceae isolates from urine cultures: A study from Puducherry
por: Sreenivasan, Srirangaraj, et al.
Publicado: (2019)

Evaluation of the effects of dexketoprofen trometamol on knee joınt: an in vivo & in vitro study
por: Sagir, Ozlem, et al.
Publicado: (2013)

Reversion of High-level Mecillinam Resistance to Susceptibility in Escherichia coli During Growth in Urine
por: Thulin, Elisabeth, et al.
Publicado: (2017)

Verocytotoxin-producing Escherichia coli, Japan, 1999–2004
por: Sakuma, Mio, et al.
Publicado: (2006)

Cooperative Actions of CRP-cAMP and FNR Increase the Fosfomycin Susceptibility of Enterohaemorrhagic Escherichia coli (EHEC) by Elevating the Expression of glpT and uhpT under Anaerobic Conditions
por: Kurabayashi, Kumiko, et al.
Publicado: (2017)

Integrating Escherichia coli Antimicrobial Susceptibility Data from Multiple Surveillance Programs
por: Stelling, John M., et al.
Publicado: (2005)

Resistance to fosfomycin is increasing and is significantly associated with extended-spectrum β-lactamase-production in urinary isolates of Escherichia coli
por: Ríos, Esther, et al.
Publicado: (2022)

Detection of Low-Level Fosfomycin-Resistant Variants by Decreasing Glucose-6-Phosphate Concentration in Fosfomycin Susceptibility Determination
por: Martín-Gutiérrez, Guillermo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7dcq6dilcq1u6t4pbehoq1edvm